The increasing prevalence of diabetes and its economic burden

American Journal of Managed Care

Volumn 6, Issue 21 SUPPL., 2000, Pages

  Basile, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE;

BELOW KNEE AMPUTATION; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DIABETES CONTROL; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; KIDNEY DISEASE; MANAGED CARE ORGANIZATION; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

BLOOD GLUCOSE; COST OF ILLNESS; COST SAVINGS; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 0033676270     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Epidemiology, complications and costs of diabetes mellitus
2. Prevalence and diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults
3. Excess costs of medical care for patients with diabetes in a managed care population
4. Economic consequences of diabetes mellitus in the US in 1997
5. The cost to health plans of poor glycemic control
6. Exploring and expanding the research agenda for diabetes in managed care
7. Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study, 11-year follow-up
8. Is fasting glucose sufficient to define diabetes?
9. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr
10. Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance
11. Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies
12. Evening insulin strategy